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Abstract
Gait festination is one of the most characteristic gait disturbances in patients with Parkinson’s disease or atypical parkinson-
ism. Although festination is common and disabling, it has received little attention in the literature, and different definitions 
exist. Here, we argue that there are actually two phenotypes of festination. The first phenotype entails a primary locomotion 
disturbance, due to the so-called sequence effect: a progressive shortening of step length, accompanied by a compensatory 
increase in cadence. This phenotype strongly relates to freezing of gait with alternating trembling of the leg. The second 
phenotype results from a postural control problem (forward leaning of the trunk) combined with a balance control deficit 
(inappropriately small balance-correcting steps). In this viewpoint, we elaborate on the possible pathophysiological substrate 
of these two phenotypes of festination and discuss their management in daily clinical practice.
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Introduction
Gait festination is among the most characteristic gait distur-
bances in patients with Parkinson’s disease (PD) or atypical 
parkinsonism [29]. Festination was already described by 
James Parkinson in his first essay on ‘The Shaking Palsy’: 
‘The propensity to lean forward becomes invincible, and 
the patient is thereby forced to step on the toes and fore 
part of the feet, whilst the upper part of the body is thrown 
so far forward as to render it difficult to avoid falling on the 
face. In some cases, when this state of malady is attained, 
the patient can no longer exercise himself by walking in his 
unusual manner, but is thrown on the toes and forepart of the 
feet; being, at the same time, irresistibly impelled to make 
much quicker and short steps, and thereby to adopt unwill-
ingly a running pace. In some case it is found necessary 
entirely to substitute running for walking; since otherwise 
the patient, on proceeding only a very few paces, would 
inevitably fall’ [33].
Gait festination is common [19], and often has a disabling 
impact on the quality of life of affected individuals. In a 
group of 81 PD patients (mean disease duration 8.5 years), 
32% of patients reported to have experienced festination 
during the previous month [19]. More than half of these 
patients reported that festination was a disabling problem, 
and 35% of patients reported frequent falls due to festina-
tion. Despite is significance, festination has thus far received 
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relatively little attention in the literature. In this viewpoint, 
we elaborate on this fascinating phenomenon. Inspired by 
our joint clinical observations, we first argue that there are 
two phenotypes of festination, then describe their possible 
underlying pathophysiological substrate, and finally elabo-
rate on their management.
Two types of festination
The term festination is derived from the Latin word festin-
are which means to hasten. Over the years, several—partly 
overlapping—definitions of festination have been proposed. 
Giladi and co-workers described festination as ‘rapid, small 
steps, done in an attempt to keep the centre of gravity in 
between the feet while the trunk leans forward involuntar-
ily and shift the centre of gravity forward’ [19]. In contrast, 
Morris and colleagues shifted the focus to the element of 
acceleration and progressive shortening of steps: ‘Festina-
tion is the shortening of each step in a long gait sequence, 
together with an increase in gait speed and involuntary for-
ward-leaning of the trunk’ [26].
Here, we argue that there is not one, but actually two 
basic phenotypes of festination (Fig. 1). Importantly, we 
hypothesize that the two phenotypes of festination are not 
mutually exclusive and can occur in the same patient. The 
first phenotype entails a primary locomotion disturbance. 
More specifically, this first basic phenotype of festina-
tion is due to the so-called sequence effect: a progressive 
shortening of step length, accompanied by a compensatory 
increase in cadence (video 1 and 2). This phenotype most 
commonly starts in the beginning of walking (e.g. during 
gait initiation, or after turning). It is strongly associated 
with freezing of gait: when the progressive shortening of 
step length and acceleration of step frequency is severe 
enough, it will ultimately result in gait freezing with alter-
nating trembling of the legs (Fig. 1) [20]. How quickly this 
happens depends on the ‘baseline’ gait pattern: the smaller 
the steps, the more likely does freezing occur [9]. Indeed, 
both festination and freezing are accompanied by rapid 
movements that tend to occur in the frequency domain of 
3–8 Hz [11]. This type of festination frequently coincides 
with freezing of gait in the same patient. However, it can 
also occur in isolation, without freezing, if there is no 
background of severe gait hypokinesia, or if the progres-
sive shortening of steps is not severe enough. Moreover, 
freezing can also result from a variety of other distur-
bances in the locomotor network [32], which is another 
reason why this festination phenotype and freezing do not 
always coincide. For those patients with another cause for 
their freezing [16], we hypothesize that this phenotype of 
festination is not a prerequisite for freezing of gait. Indeed, 
it is our impression that festination is rare in patients with 
lesion-induced freezing. However, this should be investi-
gated in future studies.
The second phenotype is not a primary locomotion dis-
turbance, but represents a secondary phenomenon, resulting 
from a combined postural deficit (forward leaning of the 
trunk) and a balance control deficit (inappropriately small 
balance-correcting steps). When there is severe forward 
leaning of the trunk, the centre of gravity will be located in 
front of the feet, and the patient will fall forward if no com-
pensatory balance-correcting steps are made [19]. In patients 
with parkinsonism, these compensatory balance-correcting 
steps are often too small [10, 27], and are therefore insuf-
ficient to restore the centre of gravity within the base of sup-
port. Therefore, another balance correcting step is needed to 
prevent a fall. When this step is again too small, yet another 
step is needed. Moreover, to prevent falling, patients increase 
their cadence, and festination emerges (video 3).
This second phenotype can be seen when observing the 
response to the retropulsion test: the balance-correcting 
steps are too small to restore the centre of gravity within the 
base of support, and patients would continue to step back-
ward if they would not be caught by the examiner [28]. This 
notion raises the question whether a propulsion test (where 
the patient is pulled towards the examiner standing in front 
of the patient) is useful to evoke festination in daily clinical 
practice. A potential drawback is that the distance between 
the examiner and the patient is not large enough to provoke 
full-blown festination (unless the examiner rapidly steps 
backward), but this should be evaluated by future studies. 
In addition to the retropulsion test, the second festination 
phenotype can also emerge during gait initiation, or dur-
ing gait, when the patient makes an unexpected small step, 
positioning the centre of gravity in front of the base of sup-
port [19]. Alternatively, the centre of gravity may also be 
positioned in front of the base of support due to an external 
balance perturbation, for example by someone who pushes 
the patient forward. Finally, forward leaning of the trunk is 
a dynamic phenomenon that may worsen during walking, 
resulting in a progressive forward shift of the centre of grav-
ity outside the base of support.
2) secondary phenomenon
shortening of steps
progressive increase of
stepping cadence
freezing of gait
1) primary phenomenon
forward leaning of the trunk
small (balance correcve) steps
fall
inial event
form of fesnaon
possible outcome
Fig. 1  Two phenotypes of festination
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Festination during other motor tasks
Festination is not restricted to gait, and can also be observed 
during upper and lower limb tapping tasks [11, 18], or dur-
ing syllable repetition [24, 25]. We suspect that festination 
during these tasks is related to the first phenotype of festina-
tion, and is thus caused by the sequence effect. Indeed, dur-
ing these latter tasks, an increase in frequency and decrease 
in amplitude are typically observed [11, 18].
Underlying mechanisms
We next elaborate on the possible pathophysiological sub-
strates. The first phenotype of festination is due to progres-
sive shortening steps and acceleration of step frequency. 
This has been related to defective cue production by the 
basal ganglia [20]. The basal ganglia are a key component 
of automatic motor control and are responsible for running 
each component of a motor plan in a timely manner (motor 
cue production) [4]. Dysfunction of the basal ganglia in par-
kinsonism may result in defective cue production, resulting 
in the above-mentioned sequence effect [9, 20]. Alterna-
tively, dysfunction of the cerebellum might also underlie 
the first phenotype of festination, as interval timing is not 
only dependent on the striatum, but also on the cerebellum 
[6]. An interesting observation in this respect is the fact that 
cerebellar excitatory theta burst stimulation facilitates gait 
speed in patients with PD when walking with small steps 
[22]. Moreover, lesion-induced freezing is associated with 
lesions within a functional network characterized by connec-
tivity to the cerebellum [16]. Although this is only indirect 
evidence, future studies might further investigate the role 
of the cerebellum in the first phenotype of gait festination.
The second phenotype is the result of combined forward 
leaning of the trunk and small balance-correcting steps. For-
ward leaning of the trunk (a stooped posture) is common in 
parkinsonism, but the degree of anterior flexion of the thora-
columbar spine varies considerably across patients, ranging 
from a relatively mild stooped posture to pronounced for-
ward bending, which is termed camptocormia [13]. Campto-
cormia can be defined as an involuntary flexion of the spine 
of at least 30° at the lumbar fulcrum or 45° at the thoracic 
fulcrum, which is present during standing or walking and 
resolves in the supine position [15]. Importantly, campto-
cormia is not a prerequisite for the second phenotype of fes-
tination, as a relatively mild stooped posture with marked 
balance-correcting steps can be sufficient. Additionally, not 
every patient with camptocormia has the second phenotype 
of festination, as it is not present in the absence of under-
scaled balance correcting steps.
A relatively mild stooped posture is presumably directly 
related to nigrostriatal degeneration, as it is often one of 
the first presenting signs in PD. On the other hand, previ-
ous studies failed to identify one single pathological process 
for camptocormia [13]. The pathophysiological substrate 
underlying small balance-correcting steps in parkinsonism 
has not been unravelled yet [31], but if it relates in any way 
on the small-stepped gait (which typically improves with 
dopaminergic stimulation), then nigrostriatal lesions could 
be involved here as well.
Treatment
Because the first phenotype of festination is so closely 
related to freezing of gait, we recommend applying the man-
agement guidelines for freezing of gait here. A recent view-
point on the management of freezing [30] recommended 
starting treatment by optimizing dopaminergic therapy, and 
we recommend doing this also in patients with the first form 
of festination. In addition, as this phenotype seems to be 
caused by defective cue production, it usually benefits from 
cueing strategies. The response to cueing tends to depend 
on the type of external cueing: spatial (visual) cues usually 
correct and regulate the scaling and amplitude generation 
during walking, whereas temporal (auditory) cues facilitate 
gait timing [34, 36]. The effect of these different cueing 
modalities should always be evaluated in each individual 
patient, to see which one is most effective [17]. Ambulatory 
cueing devices, such as visual cueing using a laser shoe [2], 
or smart glasses that enable visual cueing using augmented 
reality are now being developed [23], and should be evalu-
ated when these become available for patients.
For the second phenotype, treatment should primarily 
target the underlying postural control deficits and balance 
impairment, and not the locomotion disturbance. A mildly 
stooped posture usually responds to some degree to treat-
ment with levodopa [3], whereas it is generally perceived 
that camptocormia is not responsive to levodopa [12]. This 
is probably explained by the generally longer disease dura-
tion in patients with camptocormia compared to those with 
a milder thoracolumbar flexion. Alternatively, patients with 
camptocormia might have a more specific parkinsonian sub-
type. Treatment with botulinum toxin injections, DBS and 
spinal cord stimulation have been evaluated in patients with 
camptocormia, with varying results, and there is no evidence 
to support their use [1, 13, 14, 35]. There is also no strong 
evidence for postural education or the provision of tactile 
cues using kinesiotape [7], but we usually tend to evaluate 
its effect by referring to an experienced PD physiothera-
pist. Management of small balance-corrective steps is also 
complex. Some studies reported no effect of dopaminergic 
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medication, whereas others reported small beneficial effects 
[5, 8, 10, 21].
Importantly, all of these management options are based 
on personal experience and extrapolation from the field of 
freezing of gait. Having a clearer definition of festination 
now opens the possibility for further testing of therapeutic 
options for festination in better-defined populations.
Conclusion
In this viewpoint, we have introduced a framework for the 
presence of two phenotypes of festination. This framework 
may explain several findings and discrepancies that were 
observed in previous studies on festination [19, 20]. How-
ever, as our framework is based merely on the joint clinical 
experience of the authors, it now needs to be formally vali-
dated by future experimental work.
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